Protalix Biotherapeutics Inc (NYSE-A:PLX), a biopharmaceutical company specializing in recombinant therapeutic proteins via its ProCellEx plant cell system, announced that CEO Dror Bashan will present at the HC Wainwright 27th Annual Global Investment Conference in New York City.
Bashan’s presentation is scheduled for September 8 at 3.30pm in the Holmes II Room, Fourth Floor, with management also holding one-on-one meetings with registered investors.